March 31, 2023
March 27, 2023
March 31, 2023
March 29, 2023
New advice from the World Health Organization (WHO) says healthy children and teens may not need additional COVID-19 shots, though they may need to catch up on other routine vaccines. “The public health impact of vaccinating healthy children and adolescents […]
March 23, 2023
Rezzayo is part of a class of medications known as echinocandins, which are usually the first drugs used to treat patients suffering from bloodstream infections caused by Candida. Unlike the three approved medicines in the class, Rezzayo doesn’t require a […]
March 15, 2023
Jessica Layman estimates she has called more than 150 doctors in the past few years in her search for someone to prescribe opioids for her chronic pain. “A lot of them are straight-up insulting,” said the 40-year-old, who lives in […]
March 29, 2023
Biopharma DiveThe results are compelling when compared with approved drugs known as GLP-1 agonists that showed a reduction of between 0.5% and 0.8% in A1C after four weeks of treatment, Jefferies analysts wrote in a note to clients. Biomea also has […]
March 28, 2023
Biopharma DiveShares of Intra-Cellular Therapies rocketed up Tuesday morning, after the New York-based biotechnology company unveiled positive clinical trial results for a depression medication that some analysts called a “clear win.” The medication, known scientifically as lumateperone and commercially as Caplyta, […]
Clinical Trials, Research and Development
March 28, 2023
Biopharma DiveNovo Nordisk pioneered the use of insulin-stimulating diabetes drugs as weight loss treatments when it launched a high-dose version of its daily shot Victoza as Saxenda in 2014. It followed on that success years later with a weekly shot, marketed […]
March 27, 2023
Biopharma DiveA yearslong disagreement between the Food and Drug Administration and a developer of an experimental medicine for ALS will get a public hearing sometime in the future, setting up another high-profile debate of what amount of evidence merits an approval […]
Clinical Trials, Industry, Research and Development, Vaccines
March 27, 2023
Contract Pharma4Q Revenues: €4.3 billion (-23%) 4Q Earnings: €2.3 billion (-28%) YTD Revenues: €17.3 billion (-9%) YTD Earnings: €9.3 billion (-8%) Comments: Results in the quarter and FY reflect lower demand for COVID-19 vaccines. Approximately 2 billion doses of COMIRNATY invoiced […]
March 24, 2023
Biopharm InternationalCuria announced on March 23, 2023 that it is collaborating with Corning to expand and accelerate continuous-flow development and manufacturing programs for the chemical and biopharmaceutical industries globally. The collaboration marks the first global installation of Corning’s G1 production system […]
March 24, 2023
Contract PharmaHarm Reduction Therapeutics, a 501(c)(3) non-profit pharmaceutical company whose mission is to prevent opioid overdose deaths, signed a commercial supply agreement with Catalent for the manufacture Harm Reduction Therapeutics’ naloxone nasal spray, RiVive (3.0 mg), for the emergency treatment of […]
March 30, 2023
March 28, 2023
March 23, 2023
March 16, 2023
Copyright © 2023. All rights reserved
